SOURCE: Stock Market Alerts

May 22, 2007 09:35 ET

Investment Alerts: BTEM! May 22, 2007

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.

MIAMI, FL--(Marketwire - May 22, 2007) - Stock Market Alerts' performance stock list includes: BioStem, Inc. (OTCBB: BTEM), Merck & Co., Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN).

BioStem, Inc. (OTCBB: BTEM) is a great stock to put on your radar and watch as Stock Market Alerts initiates coverage of the company. The company issued a press release Monday after the markets closed announcing that Cryobanks International, Inc. (Cryobanks), which has agreed to be acquired by BioStem, Inc., has experienced remarkable growth as its organization announces an increase of over 300 percent in the past four years.

Great news for BTEM investors! The press release also states that Cryobanks additionally celebrates two monumental milestone as tax filings are completed which result in its first year of profitability, as well as an entrance into its 14th year of business.

The Cryobanks Company has seen its business grow all over the world in a short period of time, establishing licensees in Athens, Greece and Delhi, India. Eight additional facilities are under contract, including one in Bangkok, Thailand, which will open within the next 60 days.

"While we've had tremendous success, we also want the cord blood industry to continue to grow," says Dwight C. Brunoehler, Founder and President of CI. "Public education will be the key to ensure growth and an understanding of the overwhelming benefits of cord blood donation at delivery."

This is certainly another company for investors to watch closely! With one of the largest cord blood inventories in the country and a growing presence nationally and internationally, CI has become a leader in the industry. Accredited by the American Association of Blood Banks, the Company is one of 13 cord blood banks worldwide that form the National Marrow Donor Program's Center for Cord Blood, providing physicians and their patients access to the most diverse inventory of cord blood units in the world. Its inventory of more than 9,700 units of cord blood donations is part of international registries available to anyone who needs a transplant. That inventory has grown by more than 50 percent over the last four years.

BTEM stock closed Monday at $2.27 a share.

Cryobanks International is located in Altamonte Springs, FL. The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood (CB) are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant. There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International is well poised to help meet that need, equipped with an inventory of over 9,700 donated cord blood units placed on international registries including The National Marrow Donor Program.

Other Stocks of interest yesterday were:

Merck & Co., Inc. (NYSE: MRK) up 1% on19.7 million shares traded. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs.

Johnson & Johnson (NYSE: JNJ) up 0.1% on 10.8 million shares traded. Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of healthcare products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets.

Amgen (NASDAQ: AMGN) up 0.2% on 13.6 million shares traded. Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for BioStem, Inc. (OTCBB: BTEM). The compensation was twelve thousand dollars in 2007 from third party, ATN Enterprises, who is non-affiliated and may hold a significant position in the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information